Cargando…

CD8+ T cell responses in metastatic melanoma patients receiving an adenovirally antigen engineered dendritic cell vaccine +/- IFN-α

Detalles Bibliográficos
Autores principales: Du, Samuel, Santos, Patricia M, Tawbi, Hussein, Tarhini, Ahmad, Kirkwood, John M, Butterfield, Lisa H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645496/
http://dx.doi.org/10.1186/2051-1426-3-S2-P149
_version_ 1782400825742589952
author Du, Samuel
Santos, Patricia M
Tawbi, Hussein
Tarhini, Ahmad
Kirkwood, John M
Butterfield, Lisa H
author_facet Du, Samuel
Santos, Patricia M
Tawbi, Hussein
Tarhini, Ahmad
Kirkwood, John M
Butterfield, Lisa H
author_sort Du, Samuel
collection PubMed
description
format Online
Article
Text
id pubmed-4645496
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-46454962015-11-20 CD8+ T cell responses in metastatic melanoma patients receiving an adenovirally antigen engineered dendritic cell vaccine +/- IFN-α Du, Samuel Santos, Patricia M Tawbi, Hussein Tarhini, Ahmad Kirkwood, John M Butterfield, Lisa H J Immunother Cancer Poster Presentation BioMed Central 2015-11-04 /pmc/articles/PMC4645496/ http://dx.doi.org/10.1186/2051-1426-3-S2-P149 Text en Copyright © 2015 Du et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Poster Presentation
Du, Samuel
Santos, Patricia M
Tawbi, Hussein
Tarhini, Ahmad
Kirkwood, John M
Butterfield, Lisa H
CD8+ T cell responses in metastatic melanoma patients receiving an adenovirally antigen engineered dendritic cell vaccine +/- IFN-α
title CD8+ T cell responses in metastatic melanoma patients receiving an adenovirally antigen engineered dendritic cell vaccine +/- IFN-α
title_full CD8+ T cell responses in metastatic melanoma patients receiving an adenovirally antigen engineered dendritic cell vaccine +/- IFN-α
title_fullStr CD8+ T cell responses in metastatic melanoma patients receiving an adenovirally antigen engineered dendritic cell vaccine +/- IFN-α
title_full_unstemmed CD8+ T cell responses in metastatic melanoma patients receiving an adenovirally antigen engineered dendritic cell vaccine +/- IFN-α
title_short CD8+ T cell responses in metastatic melanoma patients receiving an adenovirally antigen engineered dendritic cell vaccine +/- IFN-α
title_sort cd8+ t cell responses in metastatic melanoma patients receiving an adenovirally antigen engineered dendritic cell vaccine +/- ifn-α
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645496/
http://dx.doi.org/10.1186/2051-1426-3-S2-P149
work_keys_str_mv AT dusamuel cd8tcellresponsesinmetastaticmelanomapatientsreceivinganadenovirallyantigenengineereddendriticcellvaccineifna
AT santospatriciam cd8tcellresponsesinmetastaticmelanomapatientsreceivinganadenovirallyantigenengineereddendriticcellvaccineifna
AT tawbihussein cd8tcellresponsesinmetastaticmelanomapatientsreceivinganadenovirallyantigenengineereddendriticcellvaccineifna
AT tarhiniahmad cd8tcellresponsesinmetastaticmelanomapatientsreceivinganadenovirallyantigenengineereddendriticcellvaccineifna
AT kirkwoodjohnm cd8tcellresponsesinmetastaticmelanomapatientsreceivinganadenovirallyantigenengineereddendriticcellvaccineifna
AT butterfieldlisah cd8tcellresponsesinmetastaticmelanomapatientsreceivinganadenovirallyantigenengineereddendriticcellvaccineifna